Literature DB >> 21496184

The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma.

E Jimi1, H Furuta, K Matsuo, K Tominaga, T Takahashi, O Nakanishi.   

Abstract

Oral squamous cell carcinomas (SCCs) are malignant tumours that frequently invade the mandibular bone and bone invasion is a common clinical problem. Recent studies have revealed that bone resorption by osteoclasts is an important step in the process of bone invasion by oral SCCs. However, the cellular and molecular mechanisms of bone invasion by oral SCCs remain unclear. Oral SCCs invade the mandibular bone through an erosive, mixed or infiltrative pattern that correlates with clinical behaviours. The expressions of interleukin (IL)-6, IL-11, tumour necrosis factor (TNF) α and parathyroid hormone-related protein (PTHrP) were higher in the infiltrative pattern than in the erosive pattern. These cytokines lead to receptor activator of NF-κB ligand (RANKL) expression or osteoprotegerin (OPG) suppression not only in oral SCC cells but also in cancer stromal cells to induce osteoclastogenesis. Taken together, oral SCCs provide a suitable microenvironment for osteoclastogenesis to regulate the balance of RANKL and OPG. In this review, we introduce recent advances in the knowledge of the cellular and molecular mechanisms, by which oral SCC invades mandibular bone based on the recent findings of our lab and others.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 21496184     DOI: 10.1111/j.1601-0825.2010.01781.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  28 in total

1.  Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.

Authors:  Chelsea K Martin; Wessel P Dirksen; Sherry T Shu; Jillian L Werbeck; Nanda K Thudi; Mamoru Yamaguchi; Tobie D Wolfe; Kristin N Heller; Thomas J Rosol
Journal:  Oral Oncol       Date:  2012-01-21       Impact factor: 5.337

Review 2.  Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.

Authors:  Kosei Nakajima; Dong Hyo Kho; Takashi Yanagawa; Melissa Zimel; Elisabeth Heath; Victor Hogan; Avraham Raz
Journal:  Cancer Metastasis Rev       Date:  2016-06       Impact factor: 9.264

3.  CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.

Authors:  Junhee Park; Xianglan Zhang; Sun Kyoung Lee; Na-Young Song; Seung Hwa Son; Ki Rim Kim; Jae Hoon Shim; Kwang-Kyun Park; Won-Yoon Chung
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

4.  Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.

Authors:  Yuvaraj Sambandam; Purushoth Ethiraj; Jessica D Hathaway-Schrader; Chad M Novince; Ezhil Panneerselvam; Kumaran Sundaram; Sakamuri V Reddy
Journal:  J Cell Physiol       Date:  2018-03-06       Impact factor: 6.384

5.  Evaluation of cortical mandibular bone in patients with oral squamous cell carcinoma.

Authors:  Gustavo Davi Rabelo; Claudia Coutinho-Camillo; Luiz Paulo Kowalski; Nathalie Portero-Muzy; Jean-Paul Roux; Pascale Chavassieux; Fabio Abreu Alves
Journal:  Clin Oral Investig       Date:  2017-06-24       Impact factor: 3.573

6.  Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.

Authors:  A Kolk; T Schuster; A Chlebowski; P Lange; K Scheidhauer; M Kesting; O Bissinger; M Schwaiger; J Dinges; J Weitz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-27       Impact factor: 9.236

7.  Imaging of mandible invasion by oral squamous cell carcinoma using computed tomography, cone-beam computed tomography and bone scintigraphy with SPECT.

Authors:  Samer G Hakim; Henning Wieker; Thomas Trenkle; Peter Sieg; Jens Konitzer; Konstanze Holl-Ulrich; Hans-Christian Jacobsen
Journal:  Clin Oral Investig       Date:  2013-07-20       Impact factor: 3.573

8.  Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid.

Authors:  Marco Mozzati; Germana Martinasso; Marina Maggiora; Matteo Scoletta; Marta Zambelli; Stefano Carossa; Manuela Oraldi; Giuliana Muzio; Rosa Angela Canuto
Journal:  Clin Oral Investig       Date:  2012-08-03       Impact factor: 3.573

9.  Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.

Authors:  Lucas Novaes Teixeira; Larissa Moreira Spinola de Castro Raucci; Gabriela Caroline Alonso; Ricardo Della Coletta; Adalberto Luiz Rosa; Paulo Tambasco de Oliveira
Journal:  Tumour Biol       Date:  2016-06-16

10.  Co-expression of CD44+/RANKL+ tumor cells in the carcinogenesis of oral squamous cell carcinoma.

Authors:  Martin Grimm; Cornelius Renz; Adelheid Munz; Sebastian Hoefert; Michael Krimmel; Siegmar Reinert
Journal:  Odontology       Date:  2013-08-25       Impact factor: 2.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.